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ABSTRACT
Background and Objectives: Laparoscopy in patients
with poor cardiac function has been the subject of con-
troversy and is considered by many surgeons a relative
contraindication.
Methods: We report the case of a patient who presented
with acute cholecystitis and choledocholithiasis concur-
rent with unstable angina. Our experience in laparoscop-
ic management of patients with calculous biliary disease
and severe coronary artery disease is examined.
Results: The patient was managed by coronary angio-
plasty and stenting immediately followed by laparoscop-
ic cholecystectomy and common bile duct exploration
under close invasive hemodynamic monitoring and low-
pressure pneumoperitoneum. Between 1996 and 2001,
39 patients with coronary artery disease and an ASA class
of III or IV underwent laparoscopic cholecystectomy.
Eight of these patients (20.5%) had common bile duct
stones necessitating laparoscopic common bile duct
exploration. No conversions were necessary, and no
major morbidity or mortalities occurred.
Conclusions: Laparoscopic cholecystectomy and com-
mon bile duct exploration can be safely performed in
patients with severe ischemic cardiac disease under close
hemodynamic monitoring and a low-pressure pneu-
moperitoneum (10 to 12 mm Hg).
Key Words: Laparoscopy, Acute cholecystitis, Ischemic
cardiac disease.
INTRODUCTION
Laparoscopy in patients with poor cardiac function has
been the subject of controversy and is considered by
many surgeons a relative contraindication. The manage-
ment of patients developing acute cholecystitis following
or concurrent with myocardial infarction or unstable
angina is particularly challenging. We report here the
case of a patient who presented with this scenario and
briefly review our experience and management strategies
in patients with severe ischemic cardiomyopathy pre-
senting with biliary calculous disease.
CASE REPORT
The patient is a 72-year-old man who presented with
right upper quadrant pain radiating to his back. He had
experienced multiple similar episodes in the past, but
had no fever, chills, nausea, or vomiting. He is a smok-
er, but has no history of alcohol abuse. He has a history
of systemic hypertension and coronary artery disease
with prior coronary angioplasty and stenting. On further
questioning, we noted a current worsening of unstable
angina pectoris despite a nitroglycerin patch that he had
recently been prescribed. In addition, he is on
furosemide and quinapril.
On physical examination, the patient was afebrile and
anicteric. His abdomen was tender in the right upper
quadrant with localized guarding and a Murphy sign was
present. He had no overt signs of heart failure.
Blood workup showed a white blood cell count of 10
400 U/L, and abnormal liver function tests with total
bilirubin 1.6 mg/dL, aspartate aminotransferase (AST)
208 IU/L, alanine aminotransferase (ALT) 254 IU/L and
alkaline phosphatase 191 IU/L. The remainder of his lab-
oratory results including amylase and lipase were nor-
mal. Ultrasonography showed cholelithiasis with a thick-
ened gallbladder wall; the common bile duct was of nor-
mal diameter. The electrocardiogram showed ST segment
and T wave abnormalities consistent with anterolateral
ischemia.
The patient was taken directly for a coronary angiogram
that revealed severely depressed left ventricular systolic
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function with an ejection fraction in the range of 20% and
severe single-vessel coronary artery disease involving a
90% and 80% sequential mid right coronary artery steno-
sis; these lesions were angioplastied and stented. After
consultation with the gastroenterologist, we decided to
proceed the following day with laparoscopy. An arterial
line and a pulmonary artery catheter were placed to
maintain optimal hemodynamics. Pneumoperitoneum
was maintained at a low pressure of 12 mm Hg. An intra-
operative cholangiogram was performed and revealed
obstruction of the distal common bile duct with multiple
filling defects and no flow of contrast in the duodenum.
A laparoscopic common bile duct exploration via chole-
docotomy was performed followed by cholecystectomy.
Operative time was 105 minutes, and estimated blood
loss was 50 cc. The patient tolerated the surgery very well
and was transferred to the surgical intensive care unit
extubated and in stable condition.
The patient was maintained postoperatively on intra-
venous hydralazine, enalapril, digoxin, nitroglycerin, mil-
rinone, and furosemide to ensure optimal filling pressure
and cardiac output. He was weaned off the milrinone
drip by postoperative day 2 at which time the pulmonary
artery catheter was removed. At 48 hours postoperative-
ly, a heparin drip was started in view of the stent place-
ment, and the patient was later placed on clopidrogel
(Plavix). A clear liquid diet was started on the second
postoperative day, and the patient was advanced to a
low-fat low-sodium diet the following day, at which point
the T-tube was clamped then the drain removed. The
liver function tests steadily returned to normal values.
Prior to discharge, an electrophysiologic study with ven-
tricular stimulation was performed followed by implanta-
tion of a cardioverter-defibrillator in view of the severe
ischemic cardiomyopathy with the increased risk of sud-
den death.
DISCUSSION
In an epidemiologic study examining the relative risk for
hospital admission for acute cholecystitis after admission
for myocardial infarction using a statewide hospital dis-
charge database and sequence symmetry analysis, it was
noted that hospitalization for myocardial infarction may
increase the risk of subsequent hospitalization for acute
cholecystitis.1 In addition, acute cholecystitis may cause a
clinical picture similar to that of cardiac ischemia with a
syndrome of abdominal fullness, nausea, diaphoresis,
chest pain, as well as angina pectoris, arrhythmias, or
nonspecific ST-T wave changes on the electrocardio-
gram.2,3 A vagally mediated cardiobiliary reflex is the
presumed cause of these changes.3 In patients with
known coronary artery disease who present with acute
cholecystitis and epigastric or chest pain or a “question-
able” electrocardiogram, the diagnosis of coronary
ischemia has to be promptly ruled out with further test-
ing, including stress testing and cardiac catheterization if
needed, before proceeding with cholecystectomy; how-
ever, surgeons must keep in mind that undue delay in
treatment may result in both cardiac and septic compli-
cations.
The management of patients presenting with acute chole-
cystitis immediately following or concurrent with myocar-
dial ischemia is very challenging. Anticoagulation or
thrombolytic therapy for myocardial infarction (MI)
increases the risk of surgical and postoperative bleeding.
Delaying surgical intervention for 6 months when the risk
of recurrent MI has returned to that of the normal popu-
lation puts the patient at risk for septic as well as other
complications of gallstone disease. Proceeding to early
coronary angiography allows the immediate assessment of
the coronary artery anatomy and potentially performing
an angioplasty. Cholecystectomy can then follow angio-
plasty. It is important to start anticoagulation in these
patients as soon as deemed safe postoperatively because
holding anticoagulation for longer periods puts patients at
risk for recurrent MI or stent thrombosis. In cases where
the anatomy is not conducive to angioplasty, such as in
triple-vessel disease, simultaneous cholecystectomy, and
coronary artery bypass grafting, can be performed and
has been previously reported.4 In patients with severely
depressed cardiac function secondary to ischemic car-
diomyopathy, the intraaortic balloon pump (IABP) has
been used successfully to significantly improve cardiac
performance so that patients can undergo definitive
cholecystectomy (Personal communication with Franklin
ME Jr.)5 We believe a definitive biliary procedure follow-
ing coronary reperfusion is a good alternative to chole-
cystostomy that has been recommended in high-risk sur-
gical patients.6 Cholecystostomy drains, although occa-
sionally useful in some critically ill ventilator-dependant
septic patients, are associated with their own morbidity,
have a mortality ranging from 5% to 36%,7 miss common
bile duct stones and ascending cholangitis, are difficult to
manage in outpatients with tube occlusion and recurrent
symptoms, and usually require readmission for cholecys-
tectomy.The next issue becomes the approach to cholecystecto-
my. Laparoscopy has traditionally been relatively con-
traindicated in patients with severe cardiac disease and
cardiac failure in view of its effect on decreasing venous
return and significant dropping of left ventricular stroke
work, cardiac index, and stroke volume. In addition,
releasing pneumoperitoneum may lead to a sudden
increase in venous blood return and subsequent conges-
tive heart failure and acute pulmonary edema. Studies8
have shown, however, that laparoscopy may be safely
performed in patients with compromised cardiac func-
tions under close hemodynamic monitoring using intra-
and postoperative pulmonary artery catheters. Trans-
esophageal echocardiography (TEE) did not prove useful
for intraoperative monitoring. Carroll BJ et al9 reported
their experience with 13 patients with severe cardiac dys-
function undergoing laparoscopic cholecystectomy with
appropriate hemodynamic monitoring and adequate
perioperative support of cardiac function. Although the
authors had only 9 successfully completed laparoscopic
cholecystectomy procedures and 1 death within 30 days
of surgery, they felt that laparoscopic cholecystectomy
can be performed safely for acute cholecystitis in patients
with severe cardiac disease. When compared with his-
torical controls, it appears to be safer than open chole-
cystectomy.
A multicenter, prospective, randomized trial10 comparing
two-stage vs one-stage management of patients with gall-
stone disease and ductal calculi demonstrated equivalent
success rates and patient morbidity for the 2 manage-
ment options but a significantly shorter hospital stay with
the one-stage laparoscopic treatment and concluded that
in fit patients (American Society of Anesthesiologists’
[ASA] class I and II), one-stage laparoscopic treatment is
the better option, and preoperative endoscopic stone
extraction should be confined to poor-risk patients, ie,
those with cholangitis or severe pancreatitis. In our own
experience with laparoscopic common bile duct explo-
ration by choledochotomy,11,12 223 patients have now
undergone such a procedure with a 96% success rate in
technically clearing the common bile duct. We apply this
one-stage approach to less fit patients (ASA III and IV)
and feel that these patients would potentially benefit
more from a lesser number of interventions, an earlier
resumption of anticoagulation, and a shorter hospital
stay. Our experience with this approach has been
extremely encouraging, and the case report presented
here only illustrates one of these scenarios. In reviewing
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our prospectively maintained database, we identified 39
patients between 1996 and 2001 with coronary artery dis-
ease and an ASA class of III or IV who have undergone
laparoscopic cholecystectomy. No conversions were nec-
essary, and no major morbidity or mortalities occurred.
Eight of these patients (20.5%) had common bile duct
stones necessitating laparoscopic common bile duct
exploration through a transcystic approach in 2 of them
and a choledochotomy in 6. The presence of common
bile duct stones was unsuspected in one of these patients
based on preoperative ultrasound and liver function
tests.
CONCLUSION
Laparoscopic cholecystectomy can be performed safely
in patients with severe ischemic cardiac disease under
close hemodynamic monitoring and a low-pressure
pneumoperitoneum (10 to 12 mm Hg). This applies as
well to patients with unstable angina, following coronary
angioplasty. In patients with common bile duct stones
and in experienced hands, a laparoscopic common bile
duct exploration can be performed in that same setting
as a one-stage procedure.
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